Induces potent and long-lasting immune responses to defined antigens or whole pathogens (particles), mainly through the ...

In this article, Cerba dives into CAR+ T-cell therapy, from patient treatment to solutions for minimal residual disease (MRD) ...

Guillain-Barré Syndrome is an uncommon, rare neurological condition in which the immune system mistakenly attacks the body's ...

Scientists have progressed from merely provoking an anti-cancer immune response to designing it ...

Recombinant antibodies are invented antibodies formed by using recombinant DNA technology. While traditional monoclonal ...

DURHAM, N.C.and SEATTLE, Jan. 28, 2025 (GLOBE NEWSWIRE) -- . (Nasdaq: HUMA), a commercial-stage biotechnology platform company developing universally implantable, bioengineered human tissue at ...

Immutep Limited (IMMP) is a promising biotech stock with a strong pipeline and solid financial foundation, making it a buy ...

Findings indicate that altering glucose metabolism in T cells boosts their therapeutic potential against melanoma, paving the way for improved immunotherapies.

Uniform protein labeling in intact tissues is a challenge. An approach that allows antibodies to seep within organs could ...

The European Medicines Agency has recommended three new medicines to treat breast and cervical cancer and ...

UCLA Health’s Outpatient Theranostics Center allows clinicians to treat up to 16 patients per day with Pluvicto and other ...